The North America point of care diagnostics
market is anticipated to reach USD 8.95 billion by 2024, according to
a new report by Grand View Research, Inc. Incorporation of advanced information
technology solutions coupled with the launch of innovative POC products with
automation and ease of use is projected to influence market progression during
the forecast period.
Moreover,
the rising adoption rate of the POC devices in order to obtain quick results
for immediate decision making for patient management is expected to provide the
market with lucrative growth avenues. Additionally, the regulatory initiatives
introduced for patient care management and rising prevalence of various
diseases is attributive to boost demand for these products in the coming years.
The
presence of a favorable funding environment in the region is attributive to
drive R&D in academic organizations and universities thereby resulting to
industrial progress through to 2024.
Browse full research report on North America PoC Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/north-america-point-of-care-poc-diagnostics-market
Further
key findings from the report suggest:
- Glucose
testing accounted for the largest share of over 41% of the market in 2015
with respect to revenue generation. Factors attributive for the estimated
large share includes presence of comprehensive product portfolio provided
by the local as well as international market participants. Moreover, rise
in the prevalence of diabetes in chronic patients and need for monitoring
glucose levels is also supportive for revenue generation of this
segment.
- Infectious
diseases point-of-care tests are expected to witness the fastest growth in
the coming years owing to the R&D carried out in this segment for an
introduction of novel tests. Infectious disease testing segments include
kits for various diseases such as HIV, HBV, respiratory syncytial virus
(RSV), pneumonia or streptococcus associated infections, HPV, influenza/flu,
HCV, MRSA, Clostridium difficile, TB &drug-resistant TB,
and HSV.
- Cardiac
markers are also anticipated to register substantial growth as a result of
an increase in incidence rate of cholesterol associated disorders and rise
in the number of cases of congestive heart failure.
- Clinics
dominated the POC diagnostic market in 2015 due to higher usage of these
tests in clinics. However, home settings for POC diagnostics are
anticipated to witness the fastest growth owing to rising usage of home
health care settings for disease monitoring in the geriatric
population.
- Assisted
living healthcare facilities are also anticipated to witness considerable
growth during the forecast period due to the property of rapid diagnostic
products to enable simple usage at primary care level and in remote
settings even with no laboratory infrastructure
- Prominent
players of this industry include Qiagen N.V., Spectral Diagnostics, Abbott
Laboratories, Siemens Healthcare, Instrumentation Laboratory, Danaher
Corporation, BioMerieux, Johnson & Johnson, Abaxis Inc., Roche
Diagnostics, Alere Inc., Nova Biomedical, Nipro Diagnostics, and Trinity
Biotech.
- Strategies
adopted by the market players include mergers and acquisitions with the
smaller entities operating in market for enhancement of the product
portfolio. The participants are involved introduction of new solutions,
and collaborations with heath care institutions in order to maintain their
global presence.
Browse more reports of this category by
Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has
segmented North America point of care diagnostics market on the basis of
product, end-use, and region:
North America Point of
Care Diagnostics Outlook, by Product (Revenue, USD Million, 2013 - 2024)
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Cardiac markers
- Infectious diseases
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus
associated infections
- Respiratory syncytial virus (RSV)
POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and drug-resistant TB POC
- HSV POC
- Other Infectious Diseases
- Primary care systems
- Hematology
- Decentralized Clinical Chemistry
- Feces
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Urinalysis
- Drug Abuse Testing
North America Point of
Care Diagnostics Outlook, by End-use (Revenue, USD Million, 2013 - 2024)
- Clinics
- Hospitals
- Assisted Living Healthcare
Facilities
- Laboratory
- Others
North
America Point of Care Diagnostics Regional Outlook (Revenue, USD Million,
2013 - 2024)
- North America
- U.S.
- Canada
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment